<DOC>
	<DOCNO>NCT00030914</DOCNO>
	<brief_summary>RATIONALE : Medroxyprogesterone venlafaxine may effective relieve hot flash . It yet know whether venlafaxine effective medroxyprogesterone relieve hot flash . PURPOSE : Randomized phase III trial compare effectiveness medroxyprogesterone venlafaxine treat woman experience hot flash .</brief_summary>
	<brief_title>Medroxyprogesterone Compared With Venlafaxine Treating Hot Flashes Women</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy medroxyprogesterone administer 1 injection v medroxyprogesterone administer 3 injection ( close accrual 1/22/03 ) v venlafaxine hot flash alleviation woman symptomatic hot flash . - Compare toxic effect regimens patient . - Determine whether cross resistance 2 drug patient . - Compare 1-year efficacy regimens patient . OUTLINE : This randomize , open-label , multicenter study . Patients stratify accord age ( 18 49 v 50 ) , current tamoxifen use ( yes v ) , current raloxifene use ( yes v ) , duration hot flash symptom ( less 9 month vs 9 month ) , average frequency hot flash per day ( 2-3 v 4-9 v 10 ) . Patients randomize 1 2 treatment arm . ( Arm II close accrual 1/22/03 . ) All patient complete daily questionnaire regard number hot flash begin day 1 continue 7 week . Patients randomize one three treatment arm .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : History breast cancer , ductal carcinoma situ , lobular carcinoma situ ( currently without evidence malignant disease ) OR Concerns take estrogen fear breast cancer Bothersome hot flash , define occurrence least 14 time per week sufficient severity make patient desire therapeutic intervention Presence hot flash least 1 month Hormone receptor status : PATIENT CHARACTERISTICS : Age : 18 Sex : Female Performance status : ECOG 01 Life expectancy : At least 6 month Cardiovascular : No prior thromboembolic disease No uncontrolled hypertension ( persistent diastolic blood pressure great 95 mm Hg and/or systolic blood pressure great 160 mm Hg ) Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Chemotherapy : More 4 week since prior antineoplastic chemotherapy No concurrent antineoplastic chemotherapy unless clinically appropriate Endocrine therapy : More 4 week since prior androgen estrogen therapy More 3 month since prior progesterone part hormone replacement therapy At least 1 year since progesterone therapy ( include megestrol ) No concurrent androgen , estrogen , progestational agent unless clinically appropriate Concurrent tamoxifen , raloxifene , aromatase inhibitor allow start 4 week ago continuation 5 week plan Other : More 2 week since prior agent treatment hot flash ( e.g. , clonidine , BellergalS , vitamin E 400 mg per day ) More 1 year since prior antidepressant ( include Hypericum perforatum [ St John 's Wort ] ) No concurrent antidepressant monoamine oxidase inhibitor No concurrent agent treatment hot flash ( e.g . clonidine , BellergalS , vitamin E 400 mg per day )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>hot flash</keyword>
</DOC>